Recorded on May 27, 2021
In this episode, Dr. Jeffrey Wolf, from the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco, explains what measurable residual disease (MRD) is, how providers can explain the role of MRD to patients, including understanding the tests used, how to counsel patients when there is MRD, where testing is done for patients treated in the community, the way MRD test results will be used in the future, and so much more. Tune in today as Dr. Wolf explores MRD with our moderator, Dr. Ken Miller!
Jeffrey L. Wolf, MD
Clinical Professor, Department of Medicine
Director, Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
Clinical Professor, Department of Medicine
Director, Myeloma Program
UCSF Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, CA
This podcast episode is supported by Amgen.
Podcast: Play in new window | Download (Duration: 27:42 — 25.4MB)